Noetik Names Dr. Emily Corse Executive Vice President of Therapeutics to Accelerate AI-Powered Therapeutics Pipeline [Yahoo! Finance]
ROCHE HOLDING LTD S/ADR (RHHBY)
NASDAQ:AMEX Investor Relations:
roche.com/investors.htm
Company Research
Source: Yahoo! Finance
to discover and develop precision cancer therapies, today announced the appointment of Emily Corse, Ph.D. as Executive Vice President, Therapeutics. In this role, Dr. Corse will oversee Noetik's therapeutics pipeline from discovery through translational development and into early clinical execution. Dr. Corse brings a combination of scientific rigor, translational insight, and operational leadership across academia, pharma, and biotech. She trained under Dr. Jim Allison, a Nobel Laureate and pioneer in cancer immunotherapy, and went on to establish her own research group at MD Anderson Cancer Center, where she laid the groundwork for a career dedicated to translating immune biology into impactful therapies. "Emily is an exceptional leader with deep expertise in cancer immunotherapy. Her proven track record, coupled with her dynamic energy, clarity of vision, and relentless drive to accelerate therapies to patients, will be instrumental as Noetik moves to translate insights from fr
Show less
Read more
Impact Snapshot
Event Time:
RHHBY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
RHHBY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
RHHBY alerts
High impacting ROCHE HOLDING LTD S/ADR news events
Weekly update
A roundup of the hottest topics
RHHBY
News
- Nine Drugmakers Strike Deals With Trump, With More to Come [Yahoo! Finance Canada]Yahoo! Finance Canada
- Year in Review: Pharmaceuticals industry continues ascent [Yahoo! Finance]Yahoo! Finance
- Genentech Announces Agreement With U.S. Government [Yahoo! Finance]Yahoo! Finance
- Genentech Announces Agreement With U.S. GovernmentBusiness Wire
- Ulcerative Colitis Market Poised for Strong Expansion During the Forecast Period (2025-2034) Driven by Biologic and Novel Therapy Adoption Landscape | DelveInsight [Yahoo! Finance]Yahoo! Finance